Search

Displaying results 4811 - 4820 of 9889 in total
  1. Drug

    Motavizumab

    go.drugbank.com/drugs/DB06310
    Investigational

  2. Drug

    BNC105

    go.drugbank.com/drugs/DB06313
    Investigational

  3. Drug

    SGX-523

    go.drugbank.com/drugs/DB06314
    Investigational

    A MET receptor tyrosine kinase inhibitor.

  4. Drug

    AZX-100

    go.drugbank.com/drugs/DB06323
    Investigational

  5. Drug

    XmAb 2513

    go.drugbank.com/drugs/DB06324
    Investigational

    XmAb 2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types.

  6. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational

  7. Drug

    RG-7795

    go.drugbank.com/drugs/DB06329
    Investigational

  8. Drug

    Tucidinostat

    go.drugbank.com/drugs/DB06334
    Investigational

  9. Drug

    Elsiglutide

    go.drugbank.com/drugs/DB06336
    Investigational

  10. Drug

    ARG098

    go.drugbank.com/drugs/DB06338
    Experimental

    ARG098 (anti-Fas IgM monoclonal antibody) was studied in a Phase I clinical trial in 2007 involving patients with rheumatoid arthritis.